The double-stranded replicative form of dengue 2 virus (DEN-2) RNA (Tonga strain) was used as a substrate to produce DNA clones of the NS1-NS2A genes via reverse transcriptase synthesis of full length cDNA followed by polymerase chain reaction amplification of the NS1-NS2A region. Products were cloned into pTZ18R for sequencing and into baculovirus for expression studies. The deduced amino acid sequence of the NS1-NS2A was almost identical to that of the S1 attenuated strain of DEN-2 Puerto Rico 159, differing in only four amino acids. The NS1 protein expressed in insect cells [Spodoptera frugiperda ] from the baculovirus recombinant was indistinguishable from authentic NS1 of DEN-infected Aedes albopictus cells in glycosylation, dimerization, cellular presentation and antigenicity. Mice injected with the expressed protein developed NSl-specific complement-fixing antibodies and were partially protected against neurological residua after intracranial challenge. The protective effect was mouse strain-and gender-specific.
Introduction
The four serotypes of dengue virus (DEN) form a subgroup within the flavivirus genus of the family Flaviviridae. They are enveloped and contain a positive sense RNA genome of approximately 10 700 nucleotides forming a single open reading frame (Mackow et al., 1987) . The gene order is 5'C prM-E-NS1-NS2A-NS2B-NS3 NS4A-NS4B-NS5 3' where C is the core protein, prM the premembrane protein, E the envelope protein, and NS1 to NS5 the non-structural proteins. The gene products are expressed as a polyprotein which is cotranslationally cleaved (Smith & Wright, 1985; Preugschat et al., 1990) . The three structural proteins (C, M and E) are incorporated into the mature virion.
DEN viruses pose a considerable world health problem. Each year they cause hundreds of thousands of cases of human disease with symptoms ranging from a benign, influenza-like, febrile illness to the severe, lifethreatening dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) (Halstead, 1988) . A major impediment to the development of a safe, effective vaccine is the perceived risk of causing DHF and DSS t Present address: Department of Biology, University of New Brunswick, Fredricton, New Brunswick, Canada.
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through antibody-dependent enhancement (ADE). ADE is believed to be due to complexes of virus and heterotypic anti-E immunoglobulin a/lowing infection of macrophages through Fc receptors (Porterfield, 1986) . Virulence variation among virus strains may also be a contributing factor (Gubler et al., 1978) .
After demonstrating that immunization with NS1 purified from yellow fever (YF) virus-or DEN virusinfected cells (authentic NS1) protected mice after challenge with the respective viruses, Schlesinger et al. (1985 Schlesinger et al. ( , 1987 suggested that, because NS1 does not occur in the virion, ADE should not occur, making NS1 a promising antigen on which to base a subunit flavivirus vaccine. This suggestion is supported by the demonstration that proteins expressed by vaccinia virus recombinants containing YF virus genes NS1-NS2B (Putnak & Schlesinger, 1990) and DEN-4 genes NS1-NS2B (Falgout et al., 1990) , or baculovirus recombinants containing DEN-4 genes CNS2A (Zhang et al., 1988) and Japanese encephalitis virus genes prM-NS2B (McCown et al., 1990 ) also protect mice from virus challenge. However the degree of protection induced by immunization with different NS1 preparations is quite variable and the influence of proteins other than NS1 could not always be excluded.
The baculovirus vector system (Smith et al., 1983) can efficiently express foreign proteins, including immunogenic DEN proteins (Zhang et al., 1988; Makino et al., 1989; Heubner et al., 1990; Deubel et al., 1991 (1988) immunized mice with DEN-4 proteins expressed by a baculovirus recombinant and although the results were consistent with the expressed NS1 being the protective antigen, because of the clone used, prM and E DEN proteins were also present.
We report here a comparison of the deduced amino acid sequences of the NS1 and NS2A genes of the avirulent isolate Tonga 1974 DEN-2 strain 1251 with those published for other DEN-2 isolates. We also describe the construction of DEN-2 NSI-NS2A baculovirus recombinants and report the immunoreactivity, antigenicity and molecular properties of NS1 protein expressed by them in insect cells.
Methods
Cells and viruses. DEN-2 virus strain 1251 was grown in the C6/36 clone of Aedes albopictus cells (Igarashi, 1978) . The DEN-2 strain New Guinea C was used to challenge mice by the intracranial inoculation route. A recombinant strain of Autographa californica nuclear polyhedrosis virus (AcNPV) containing a fl-galactosidase gene outside the polyhedfin gene (vETL-]Lgal; Crawford & Miller, 1988) , and recombinants made from it, were grown in Spodopterafrugiperda (Sf-9) cells. Plasmids pTZ18R and pAcRP23 and recombinants made from them were propagated in Escherichia coli DH5c~(F') cells.
Cloning of DEN-2 NS1 NS2A genes. Total RNA was extracted from DEN-2-infected C6/36 cells, and the segment containing the NS1 and NS2A genes was copied as cDNA and amplified by procedures which have been described (Maguire, 1986; Chen et al., 1992) . Briefly, DEN-2 replicative form dsRNA was separated from the cell lysate by Whatman CFll cellulose column chromatography and used as a template to synthesize cDNA with reverse transcriptase primed with a synthetic oligonucleotide (QXY-1) which was complementary to 20 nucleotides (4123 to 4142; Hahn et al., 1988) at the 3' end of the NS2A gene. The primer also contained a potential KpnI cleavage site and a translation termination codon. The cDNA was amplified by the polymerase chain reaction using QXY-1 and a second oligonucleotide, either QXY-2 which represented 21 nucleotides (2401 to 2421) at the 3' end of the E gene, or QXY-3 representing nucleotides 2298 to 2320 in the E gene. QXY-2 and QXY-3 contained a translation initiation codon and a potential BarnHI cleavage site. The amplified products consisted of DEN-2 NS1 NS2A genes preceded by nucleotide sequences coding for signal peptides of either four amino acids, using primer QXY-2, or 41 amino acids using primer QXY-3. Both contained a BamHI cleavage site at the 5' end and a KpnI site at the 3' end. The amplified DNAs were cloned into pTZ 18R as KpnI-BamHI fragments to make recombinant plasmids pTZD2N1 (from primer QXY-2) and pTZD2N2 (from primer QXY-3). Subclones for sequencing were made from fragments generated by a series of digestions with suitable restriction endonucleases.
Nucleotide sequencing. Nucleotide sequences were determined by the chain termination method of Sanger et al. (1977) using the T7 fragment of DNA polymerase (Amersham) with dsDNA extracted from subclones of pTZD2N2 as templates, and forward and reverse primers (Promega). The nucleotide and deduced amino acid sequences were compared with published DEN-2 sequences using the FASTA programme (Pearson & Lipman, 1988) .
Construction of baculovirus recombinants. The A. californiea shuttle vector pAcRP23 (Possee & Howard, 1987) contains part of the polyhedrin gene interrupted by a BamHI restriction site adjacent to the polyhedrin promoter followed by a KpnI site 460 bases downstream. Amplified DEN-2 NSI-NS2A ds cDNA was cloned into these sites to construct recombinant plasmids pQXD2N 1 and pQXD2N2 containing the DEN-2 NS I-NS2A genes preceded by nucleotide sequences coding for signal peptides of either four or 41 amino acids respectively. The recombinant plasmids were sequenced through the junctions between the vector and the DEN cDNA to confirm that the cDNA was correctly inserted.
DEN recombinant DNA and genomic DNA from vETL-fl-gal were cotransfected into Sf-9 cells with Lipofectin (Bethesda Research Laboratories) to generate DEN recombinant viruses by homologous recombination. The progeny virus was added to Sf-9 cells under agarose containing X-gal. Viruses that formed blue plaques of cells in which polyhedra could not be discerned were screened by dot hybridization with a aZP-labelled DEN cDNA probe. Baculoviruses containing DEN-2 sequences were plaque-purified three times. The resultant baculovirus recombinants were identified as AcD2N1 (containing nucleotides coding for a four amino acid signal sequence) and AcD2N2 (with nucleotides coding for a 41 amino acid signal sequence).
To confirm that the entire cDNA had been transferred into the baculovirus genome, the viral DNA was extracted from recombinantinfected Sf-9 cells and the DEN-2 sequence encoding NS1 and NS2A was isolated by digestion with BamHI and KpnI. The digestion products were separated by electrophoresis in an agarose gel, transferred to a cellulose nitrate membrane and probed with a2p. labelled nick-translated DEN-2 NS1 DNA extracted from pTZD2N2. This analysis revealed that the predicted 1.74 kb DNA fragment and the 1.84 kb fragment were present in the recombinant baculovirus DNA of AcD2N 1 and AcD2N2 respectively and were similar in size to the corresponding fragments in the intermediate recombinant vectors pQXD2N1 and pQXD2N2 (Fig. 1) .
Monoclonal antibodies' (MAbs)
. BALB/c mice were immunized with DEN-2 New Guinea virus which was extracted from infected suckling mouse brain. Hybridomas were prepared from their spleen cells by a method which has been described (Austin & Webster, 1986) . Three DEN-2 type-specific anti-NSl MAbs were used in this study. MAbs 123 and 298 belong to isotype G2a and MAb 237 is isotype G2b. Two of them (MAbs 237 and 298) fix complement when reacting with DEN-2 antigen. None was completely effective in passive protection experiments, but MAb 123 protected 22% of mice and MAb 298 protected 47 %.
Immunofluorescence assays. Sf-9 cells grown on glass coverslips were infected with AcNPV recombinant viruses for 48 h at 28 °C. The cells, either fixed with chilled acetone or unfixed, were then incubated with a 1:25 dilution of an NSl-specific MAb. The second antibody used was anti-mouse immunoglobulin conjugated with fluorescein isothiocyanate (Amersham).
Western blot analysis. Proteins separated by SDS-PAGE were electrophoretically transferred using a semi-dry transfer unit (Hoefer) onto nitrocellulose membranes (Amersham). The membrane was preincubated in PBS containing 2 % foetal bovine serum (FBS) and 0-002% Tween-20 before being incubated with a 1:25 dilution of an NSl-specific MAb. After several washings, the membrane was incubated successively in a 1:500 dilution of biotinylated anti-mouse immunoglobulin and then in peroxidase-streptavidin (Amersham), both for 1 h at 37 °C. The membrane was washed and bound antibodies were visualized by reaction with 0"06 % 4-chloro-1-naphthol in 0'015 % hydrogen peroxide.
Protein labelling in Sf-9 and C6/36 cells. Before labelling, cells were washed twice and incubated in methionine-free medium for 1 h. Sf-9 cells were pulse-labelled for 6 h at 24 h post-infection with 40 gCi of [35S]methionine/ml. The DEN-infected C6/36 cells were pretreated 96 h post-infection with 3 gg/ml of actinomycin D and labelled 1 h later with 100 ~LCi of [35S]methionine/ml in the presence of 3 lag/ml of actinomycin D. To analyse intracellular proteins, cells were washed twice with cold PBS and lysed with cold radioimmunoprecipitation assay (RIPA) buffer (100 mM-Tris-HC1 pH 7.5, 150 mM-NaC1, 10 mM-EDTA, 0"1% SDS, 1% NP40, 1% sodium deoxycholate) containing 100 ~tg/ml PMSF. After 5 min incubation on ice, cellular extracts were clarified by centrifugation for 5 rain in a microfuge.
Radioimmunoprecipitation (RIP). 3~S-labelled proteins were immuno-
precipitated by adding an equal volume of NSl-specific MAb and incubating for 3 h at 4 °C on a mechanical shaker. An equal volume of a 10 % suspension of Protein A-Sepharose (Sigma) in RIPA buffer was added to adsorb the antigen-antibody complexes and incubation continued for another 2 h. The Protein A-Sepharose was washed twice in RIPA buffer, suspended in SDS PAGE sample buffer, boiled for 4 min and the proteins were resolved in 12-5 % SDS~olyacrylamide gels. Proteins were located on the dried gels by autoradiography.
Endoglycosidase H (endo H) treatment.
Immune complexes were prepared as described above and treated with 1 milliunit of endo H (Boehringer-Mannheim).
Enzyme immunoassay (EIA). Antigens were prepared from infected
Sf-9 cells either by formalin-fixing cells growing in 96-well microplates (Figueiredo & Shope, 1987) or by sonicating a suspension of the cells in phosphate-buffered 1 M-NaC1 (pH 7.2) for 1 min (Rota et al., 1990) and centrifuging at 10000 r.p.m, for 5 min. Fifty gl of diluted supernatant was added to 96-well microplates. Before testing, nonspecific binding sites were blocked by adding PBS containing 2 % FBS and 0.025% Tween-20. A 1:50 dilution of MAb was added to the antigen and the bound antibody was detected by adding, in series, biotinylated anti-mouse immunoglobulin and streptavidin-peroxidase. After the addition of each reagent the microplate was incubated for 1 h at 37 °C and then washed three times. Orthophenylene diamine in hydrogen peroxide was used to detect bound peroxidase. After stopping of the reaction with 2 M-sulphuric acid, the absorbance of the samples was read at 490nm (A490) on an EAR400 plate reader (SLT Labinstruments).
Mouse immunization and protection assays. The immunizing antigen
was prepared by lysing 5 x 106 infected Sf-9 cells with non-denaturing buffer and dialysing against PBS at 4 °C. Western blot analysis was used to confirm that the NS1 protein was in the dimeric configuration which has been shown to be more antigenic than the monomer (Falconar & Young, 1990) . Cells infected with AcD2N2 did not produce enough NS1 protein to be detected against background in Coomassie blue-stained gels, but by determining the least amount of serum albumin which could be detected by this method it was estimated that there was less than 2 gg per ml of NS1 in the immunogen. Mice were injected intraperitoneally with 100 gl of antigen emulsified with Freund's complete adjuvant, followed 3 weeks later by 50 gl of antigen without adjuvant. One week later the animals were bled from the tail and then challenged by intracranial inoculation of approximately 100 LDs0 of DEN-2 New Guinea. Signs of central nervous system (CNS) disease and deaths were recorded for 21 days. Pre-challenge sera were assayed for DEN-specific antibodies by microtitre complement fixation (CF) tests using an antigen extracted from infected suckling mouse brain (Hawkes, 1979) , and by EIA and RIP using lysed DEN-2 Tongainfected C6/36 cells as antigen.
Results

Sequence analysis
The DEN sequence in pTZD2N2 was 1842 nucleotides long consisting of the complete NS1 and NS2A genes of DEN-2 Tonga flanked by 123 nucleotides from the 3' end of the E gene and nine nucleotides from the 5' end of the NS2B gene (Fig. 2) . Analysis of the deduced amino acid sequence of NS1 predicted a protein closely related structurally to those of other flavivirus NS 1 molecules as indicated by the hydropathy profile (not shown) and the conservation of the 12 cysteine residues, 15 of 16 proline residues and two potential glycosylation sites.
Comparison of the Tonga NS 1 sequence with 15 other DEN-2 NS1 sequences contained in the GenBank protein database (release number 69) revealed that the amino acid sequence of the Tonga strain was most closely related to that of the attenuated DEN-2 Puerto Rico 159 S1 strain (Hahn et al., 1988) (99"4 % identity) and least related (92.6% identity) to that of D80-100. The latter strain was isolated from a 4-month-old DHF patient in Thailand (Blok et al., 1991) . The nucleotide and amino acid differences between the naturally avirulent DEN-2 Tonga 251 strain and the attenuated DEN-2 strains Puerto Rico 159 S1 and 16681-PDK53 are shown in Table 1 . The amino acid sequence of NS2A was compared with four DEN-2 NS2A sequences in the database. The sequence of DEN-2 Tonga was 99.1% identical to that of the S1 strain from Puerto Rico, 97.2% with the New Guinea strain, 96"8% with the Jamaica strain and 95-4 % with the vaccine strain 16681-PDK53.
Analysis of expressed DEN proteins
Sf-9 cells were infected with recombinant baculoviruses and screened for expression of DEN-2 NS1 antigen by EIA using DEN-2 NSl-specific MAbs. The results showed that AcD2N2 (41 amino acid signal sequence) (1988) , and the NS1-NS2A cleavage site is according to Hori & Lai (1990) . The ~derlined amino acids indicate potential glycosylation sites. expressed DEN-2 NS 1 protein, but AcD2N 1 (four amino acid signal sequence) did not. This was confirmed by Western blot analysis using the same MAbs. The recombinant protein migrated with the same electrophoretic mobility as authentic NS 1 expressed by DEN-2 in C6/36 cells, indicating that the signal sequence and NS2A were either cleaved off during processing or not expressed (Fig. 3) . Western blot analysis of the recombinants using a hyperimmune mouse serum which was known to contain anti-NS2A antibodies failed to detect a protein with the same Mr as authentic NS2A. The cellular location of the expressed NS1 in recombinant-infected Sf-9 cells was investigated by indirect immunofluorescence of acetone-fixed and unfixed cells using NSl-specific MAbs (Fig. 4) . No immunofluorescence was detected in AcD2Nl-infected cells, but fluorescence occurred on both fixed and unfixed AcD2N2-infected cells. The pattern of fluorescence on unfixed cells indicated that the NS1 expressed by AcD2N2-infected Sf-9 cells had been transported to the cell surface.
The antigenicity of the recombinant protein was analysed by EIA using MAbs directed against NS1 protein. Three MAbs that recognize at least two different epitopes on DEN-2 NS1 produced in C6/36 cells reacted with the recombinant NS1 protein in formalin-fixed AcD2N2-infected Sf-9 cells (Table 2) .
Authentic NS1 occurs as a dimer which is dissociated into monomers when heated (Winkler et al., 1988) . To ascertain whether or not the protein expressed by AcD2N2 also assumes the dimer structure, a lysate of infected Sf-9 cells was subjected to SDS-PAGE with or without prior boiling. Western blot analysis of the separated proteins showed that NS1 expressed by AcD2N2 behaved like the authentic protein with an M r of 79K when unheated, and an Mr of 45K after boiling. ? Formalin-fixed infected C6/36 cells (DEN-2/Tonga) and Sf-9 cells (AcD2N2 and AcD2E2).
:~ AcD2E2 is a baculovirus recombinant which expresses DEN protein E. § A4~o.
There are two potential glycosylation sites on authentic NS1 protein (Smith & Wright, 1985) . The glycosylation of the recombinant protein was investigated by analysis before and after endo H digestion.
[3~S]Methionine-labelled infected cells were lysed and the NS1 protein precipitated with MAb. The precipitated proteins were digested with endo H and the products separated by SDS-PAGE. The endo H treatment reduced the M r of the recombinant NS1 from 45K to 41K indicating that it was glycosylated (Fig. 5) .
Immunogenicity of baculovirus recombinant antigen in mice
Groups of 6-week-old male and female BALB/c mice were immunized with lysed Sf-9 cells infected with AcD2N2, AcD2N1, vETL-fl-gal, or with DEN-2 New Guinea. Sera collected from the mice immunized with AcD2N2 contained DEN-2 NSl-specific antibodies detectable by EIA, CF tests and RIP (Table 3 ; Fig. 6 ). After challenge with DEN-2 New Guinea virus all of the female mice were protected from illness and death whereas all of the males developed symptoms of CNS disease and most of them died. Immunization with the recombinant AcD2N1 failed to stimulate antibody production or to protect mice. To discover whether this gender difference in protection by AcD2N2 occurred in other strains of mice, a second experiment was done using CBA/T6T 6 and random-bred mice as well as BALB/c mice (Table 4) . Screening of the prechallenge sera by RIP showed that mice in all groups developed NSl-specific antibodies. Although protection was not complete, fewer female than male BALB/c and random-bred mice developed signs of CNS disease. None of the CBA/T,T 6 mice was protected.
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Discussion
Some strains of DEN, including DEN-2 Tonga, grow very poorly in cell cultures making it difficult to obtain sufficient viral RNA for cDNA copying and cloning. The strategy of using replicative form dsRNA rather than virion RNA as a template for cDNA synthesis was successful and avoided the requirement to grow large amounts of virus. The deduced amino acid sequences of NS 1 and NS2A had very close similarities to those of the S1 strain of DEN-2 Puerto Rico 159 confirming the close relationship between these two viruses shown by Rico-Hesse (1990) on the basis of identical 240 nucleotide sequences spanning the junction between the E and NS 1 genes. The S1 strain of DEN-2 Puerto Rico 159 was selected by Eckels et aI. (1976) for reduced virulence, and the 1251 strain of DEN-2 Tonga is avirulent both in humans (Gubler et al., 1978) and in suckling mice (F. J. Austin, unpublished results). However any speculation that the close homology between DEN-2 Tonga 251 and DEN-2 Puerto Rico 159 S 1 is related to lack of virulence could be challenged on the basis of the 5.4% sequence difference between DEN-2 Tonga 251 and another avirulent DEN-2 virus, 16681-PDK53. The determinants of virulence in flaviviruses are believed to be encoded in the E protein (Hahn et al., 1987; Barrett et al., 1990; Lobigs et al., 1990) .
NS 1 protein was expressed in Sf-9 cells by recombinant AcD2N2, which has a 41 amino acid signal peptide and is flanked by the NS2A gene, but not by a similar recombinant (AcD2N1) with a signal peptide of only four amino acids. No NS2A protein was detected but its presence or the presence of the signal peptide cannot be excluded. Correct proteolytic processing of DEN-4 NS 1 in a vaccinia virus recombinant has been shown to require an N-terminal hydrophobic signal peptide, derived from the preceding E glycoprotein, and the C-terminal flanking NS2A (Falgout et al., 1989) . Our results indicate that the former is also necessary for expression of NS1 in baculovirus recombinants. Both of our recombinants contained a C-terminal flanking NS2A but it was probably not necessary for expression of NS1 by recombinant AcD2N2 because Heubner et al. (1990) , McCown et al. (1990) and Despr~s et al. (1991) all obtained flavivirus NS1 expression by baculovirus recombinants in which there was no NS2A proteincoding region.
Recombinant and authentic DEN-2 NS1 were virtually identical with respect to M r, cell surface expression, dimeric configuration, glycosylation and antigenicity, suggesting that the recombinant NS1-NS2A segment is processed in a similar way in both Sf-9 cells and DEN-infected C6/36 cells.
Immunization with recombinant NS1 expressed by AcD2N2 stimulated the production of NSl-specific antibody in random-bred mice and two inbred strains but only BALB/c females, and to a lesser extent randombred females, were protected after challenge. The failure of antibody to protect CBA/TGT 6 mice and BALB/c and random-bred males suggested that the genetic constitution and gender of the mice are important components of protection by baculovirus-expressed NS1. The importance of host genes in determining the severity of many viral infections and in controlling the immune response is well documented (Brinton et al., 1984; McDevitt, 1984; Brownstein et al., 1991) . To our knowledge a gender difference in protection of mice by expressed DEN virus proteins has not been reported previously. Presumably it is a manifestation of the greater immune reactivity of females compared to males due to the effects of sex hormones (Ahmed et al., 1985) . Mouse strain and gender differences may be the reasons why experiments to protect mice by immunization with flavivirus NS1 protein have produced variable results.
The method by which NS 1 and NS 1-specific antibodies protect mice from challenge is unclear. The original proposal was complement-mediated cytolysis (CMC) of DEN-infected cells (Schlesinger et al., 1985) . Antibody impairment of virus spread and immune recognition of cell surface NS 1 protein by macrophages and T cells are other possibilities which have been suggested (Gould et al., 1986) . Henchal et al. (1988) found that at least one non-complement-fixing MAb passively protects mice, indicating that a mechanism other than CMC may be implicated. Although passive protection of mice by NS 1-specific MAbs against YF virus and DEN has been shown (Schlesinger et al., 1985; Gould et al., 1986; Henchal et al., 1988) , our demonstration that circulating anti-DEN NS1 complement-fixing antibody failed to protect CBA/T6T6 mice indicates that other factors are involved.
Before DEN-2 NS1 can be utilized as a component of a subunit DEN vaccine it will be necessary to do protection experiments comparing authentic NS1 with recombinant NS 1, with NS 1 from different virus strains and with NS1 produced in different expression systems. This should disclose whether or not the gender-related and mouse strain differences in protection are due to the NS1 protein itself, the virus strain from which it was obtained or the expression system.
